| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adding PD-1 inhibition to chemoradiotherapy for oesophageal cancer
|
van Laarhoven, Hanneke W M
|
|
|
24 |
4 |
p. 309-310
|
artikel
|
| 2 |
Artificial intelligence-based model for lymph node metastases detection on whole slide images in bladder cancer: a retrospective, multicentre, diagnostic study
|
Wu, Shaoxu
|
|
|
24 |
4 |
p. 360-370
|
artikel
|
| 3 |
Cancer surveillance as an alternative to prophylactic total gastrectomy in hereditary diffuse gastric cancer: a prospective cohort study
|
Asif, Bilal
|
|
|
24 |
4 |
p. 383-391
|
artikel
|
| 4 |
Correction to Lancet Oncol 2023; 24: 228–38
|
|
|
|
24 |
4 |
p. e146
|
artikel
|
| 5 |
Correction to Lancet Oncol 2021; 22: 74–84
|
|
|
|
24 |
4 |
p. e146
|
artikel
|
| 6 |
Current drug development and trial designs in neuro-oncology: report from the first American Society of Clinical Oncology and Society for Neuro-Oncology Clinical Trials Conference
|
Rahman, Rifaquat
|
|
|
24 |
4 |
p. e161-e171
|
artikel
|
| 7 |
Cyber-attacks on health-care systems
|
Devi, Sharmila
|
|
|
24 |
4 |
p. e148
|
artikel
|
| 8 |
Endoscopic surveillance: time for a paradigm shift in hereditary diffuse-type gastric cancer management?
|
van der Post, Rachel Sophia
|
|
|
24 |
4 |
p. 311-312
|
artikel
|
| 9 |
Equitable cancer care at any age
|
The Lancet Oncology,
|
|
|
24 |
4 |
p. 307
|
artikel
|
| 10 |
Expression of concern—Atezolizumab, vemurafenib, and cobimetinib in patients with melanoma with CNS metastases (TRICOTEL): a multicentre, open-label, single-arm, phase 2 study
|
The Editors of The Lancet Oncology,
|
|
|
24 |
4 |
p. e145
|
artikel
|
| 11 |
From the European Medicines Agency to Project Orbis: new activities and challenges to facilitate UK oncology drug approval following Brexit
|
Lythgoe, Mark P
|
|
|
24 |
4 |
p. e150-e160
|
artikel
|
| 12 |
Health-related quality of life with pembrolizumab or placebo plus chemotherapy with or without bevacizumab for persistent, recurrent, or metastatic cervical cancer (KEYNOTE-826): a randomised, double-blind, placebo-controlled, phase 3 trial
|
Monk, Bradley J
|
|
|
24 |
4 |
p. 392-402
|
artikel
|
| 13 |
High concentrations of aflatoxin in Ugandan grains sparks public health concern
|
Gourd, Elizabeth
|
|
|
24 |
4 |
p. 315
|
artikel
|
| 14 |
India rolls out HPV vaccination
|
Burki, Talha Khan
|
|
|
24 |
4 |
p. e147
|
artikel
|
| 15 |
Multinational Association of Supportive Care in Cancer (MASCC) clinical practice guidelines for the prevention and management of acute radiation dermatitis: international Delphi consensus-based recommendations
|
Behroozian, Tara
|
|
|
24 |
4 |
p. e172-e185
|
artikel
|
| 16 |
Prevalence of human papillomavirus DNA and p16INK4a positivity in vulvar cancer and vulvar intraepithelial neoplasia: a systematic review and meta-analysis
|
Li, Zhuang
|
|
|
24 |
4 |
p. 403-414
|
artikel
|
| 17 |
Promoting cancer prevention through World Cancer Day in Nigeria
|
Chidebe, Runcie C W
|
|
|
24 |
4 |
p. 319-322
|
artikel
|
| 18 |
Radiotherapy facilities after the Türkiye–Syria earthquakes: lessons from the tragedy
|
Anacak, Yavuz
|
|
|
24 |
4 |
p. 312-314
|
artikel
|
| 19 |
Rare primary prostate cancer presenting with testicular and hip pain
|
Au, Matthew
|
|
|
24 |
4 |
p. e186
|
artikel
|
| 20 |
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry
|
Cortellini, Alessio
|
|
|
24 |
4 |
p. 335-346
|
artikel
|
| 21 |
Tailored immunotherapy approach with nivolumab with or without ipilimumab in patients with advanced transitional cell carcinoma after platinum-based chemotherapy (TITAN-TCC): a multicentre, single-arm, phase 2 trial
|
Grimm, Marc-Oliver
|
|
|
24 |
4 |
p. 347-359
|
artikel
|
| 22 |
Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial
|
Sweeney, Christopher J
|
|
|
24 |
4 |
p. 323-334
|
artikel
|
| 23 |
The UK's re-entry into the Horizon Europe programme
|
Devi, Sharmila
|
|
|
24 |
4 |
p. 318
|
artikel
|
| 24 |
Toripalimab combined with definitive chemoradiotherapy in locally advanced oesophageal squamous cell carcinoma (EC-CRT-001): a single-arm, phase 2 trial
|
Zhu, Yujia
|
|
|
24 |
4 |
p. 371-382
|
artikel
|
| 25 |
Training workshop to promote tobacco control in African countries
|
Das, Manjulika
|
|
|
24 |
4 |
p. e149
|
artikel
|
| 26 |
US Air Force to study nuclear missile base lymphomas
|
Furlow, Bryant
|
|
|
24 |
4 |
p. 316
|
artikel
|
| 27 |
Use of artificial intelligence to enhance detection of nodal metastases
|
Forghani, Reza
|
|
|
24 |
4 |
p. 308-309
|
artikel
|
| 28 |
US Government sues to halt carcinogenic air pollution
|
Furlow, Bryant
|
|
|
24 |
4 |
p. 317
|
artikel
|
Tijdschrift beschrijving